{"component": "definition", "props": {"groups": [{"snippet": "has the meaning set forth in the preamble hereto.", "snippet_links": [{"key": "the-preamble", "type": "clause", "offset": [29, 41]}], "size": 56, "samples": [{"hash": "YVxv6bPJ0r", "uri": "/contracts/YVxv6bPJ0r#abbvie", "label": "Collaboration, License and Option Agreement (Xilio Therapeutics, Inc.)", "score": 36.3483915127, "published": true}, {"hash": "e6P6cuJ8g73", "uri": "/contracts/e6P6cuJ8g73#abbvie", "label": "License Agreement (Sionna Therapeutics, Inc.)", "score": 36.0444900753, "published": true}, {"hash": "7oN7HH5UG0i", "uri": "/contracts/7oN7HH5UG0i#abbvie", "label": "License Agreement (Sionna Therapeutics, Inc.)", "score": 35.6967830253, "published": true}], "hash": "8bccce1d0361cba936f9f507ba47a5ce", "id": 1}, {"snippet": "means AbbVie Inc.", "snippet_links": [], "size": 13, "samples": [{"hash": "aSXTtwn9LLz", "uri": "/contracts/aSXTtwn9LLz#abbvie", "label": "364 Day Term Loan Credit Agreement (AbbVie Inc.)", "score": 28.6789869952, "published": true}, {"hash": "7Aa0qUB12CW", "uri": "/contracts/7Aa0qUB12CW#abbvie", "label": "364 Day Term Loan Credit Agreement (AbbVie Inc.)", "score": 27.3750855578, "published": true}, {"hash": "daaYXBIguH9", "uri": "/contracts/daaYXBIguH9#abbvie", "label": "Three Year Term Loan Credit Agreement (AbbVie Inc.)", "score": 26.7412731006, "published": true}], "hash": "63c33d603c3cbf07138b8bf66b0e7141", "id": 2}, {"snippet": "means AbbVie Inc. a Delaware corporation", "snippet_links": [{"key": "delaware-corporation", "type": "clause", "offset": [20, 40]}], "size": 6, "samples": [{"hash": "i0uskWnErEr", "uri": "https://www.sec.gov/Archives/edgar/data/1578845/000119312519181327/d771837dex991.htm", "label": "Allergan PLC", "score": 14.4784394251, "published": false}, {"hash": "2TWRqAgiIic", "uri": "https://www.sec.gov/Archives/edgar/data/1551152/000110465919037446/a19-12093_1ex99d1.htm", "label": "AbbVie Inc.", "score": 14.4784394251, "published": false}, {"hash": "hgysoZoX8wN", "uri": "https://www.abbvie.com/content/dam/abbvie-dotcom/uploads/PDFs/allergan/abbvie-allergan-announcement.pdf", "label": "Definitive Transaction", "score": 14.1704312115, "published": false}], "hash": "703d8ed3d48bdad8384d8f099b2ea41a", "id": 3}, {"snippet": "has the meaning set forth in the introductory paragraph of this Agreement.", "snippet_links": [{"key": "introductory-paragraph", "type": "definition", "offset": [33, 55]}, {"key": "this-agreement", "type": "clause", "offset": [59, 73]}], "size": 3, "samples": [{"hash": "5SCur6Qdhxc", "uri": "/contracts/5SCur6Qdhxc#abbvie", "label": "Settlement and License Agreement (Coherus BioSciences, Inc.)", "score": 34.8453114305, "published": true}, {"hash": "2NJ1UAPcleB", "uri": "/contracts/2NJ1UAPcleB#abbvie", "label": "Settlement and License Agreement (Alvotech Lux Holdings S.A.S.)", "score": 33.295687885, "published": true}, {"hash": "hC9Qe8ccxZz", "uri": "/contracts/hC9Qe8ccxZz#abbvie", "label": "Settlement and License Agreement (Alvotech Lux Holdings S.A.S.)", "score": 33.1971252567, "published": true}], "hash": "023143755387a862f548e4fc46d62fd6", "id": 4}, {"snippet": "has the meaning given to that term in the Preamble.", "snippet_links": [{"key": "the-preamble", "type": "clause", "offset": [38, 50]}], "size": 3, "samples": [{"hash": "fYM5dy47Z0G", "uri": "/contracts/fYM5dy47Z0G#abbvie", "label": "Expenses Reimbursement Agreement (AbbVie Inc.)", "score": 30.4784394251, "published": true}, {"hash": "9vpA1W8aslr", "uri": "/contracts/9vpA1W8aslr#abbvie", "label": "Expense Reimbursement Agreement (Allergan PLC)", "score": 30.4784394251, "published": true}, {"hash": "lqeToV2ILIb", "uri": "/contracts/lqeToV2ILIb#abbvie", "label": "Reimbursement Agreement", "score": 24.1704312115, "published": true}], "hash": "490cbbc6151b7c795a2a0148ae85833a", "id": 5}, {"snippet": "means AbbVie Inc., a Delaware corporation.", "snippet_links": [{"key": "delaware-corporation", "type": "clause", "offset": [21, 41]}], "size": 3, "samples": [{"hash": "7oKVEgPdKPZ", "uri": "/contracts/7oKVEgPdKPZ#abbvie", "label": "Merger Agreement (Amgen Inc)", "score": 32.8384668036, "published": true}, {"hash": "4oxy23A1zy6", "uri": "https://investors.abbvie.com/static-files/599a19b1-48a1-44f8-9df4-0fab78b35e0f", "label": "investors.abbvie.com", "score": 9.167008898, "published": false}, {"hash": "j0l9vyU4gmK", "uri": "https://www.sec.gov/Archives/edgar/data/1551152/000104746912011334/a2212254zex-4_3.htm", "label": "AbbVie Inc.", "score": 7.9650924025, "published": false}], "hash": "6c3172b63135c3d3313568a8f24a95ba", "id": 6}, {"snippet": "means AbbVie, Inc., its directors, officers, employees, agents, representatives, successors, and assigns; and the joint ventures, subsidiaries, partnerships, divisions, groups, and affiliates controlled by AbbVie, Inc. (including Venice Subsidiary, LLC), and the respective directors, officers, general partners, employees, agents, representatives, successors, and assigns of each.", "snippet_links": [{"key": "joint-ventures", "type": "definition", "offset": [114, 128]}, {"key": "general-partners", "type": "definition", "offset": [295, 311]}], "size": 3, "samples": [{"hash": "iijxFFfDcTL", "uri": "https://www.ftc.gov/system/files/documents/cases/191_0169_abbvie_and_allergan_-_do.pdf", "label": "www.ftc.gov", "score": 10.1704312115, "published": false}], "hash": "8bd8e09b3b1a8383fbef6d5859cdcbbd", "id": 7}, {"snippet": "s Solicitors\u201d means Herbert Smith Freehills LLP of Exchange House, Primrose Street, London EC2A 2EG; \u201cAgents\u201d means directors, officers, employees and professional advisers;", "snippet_links": [{"key": "professional-advisers", "type": "clause", "offset": [151, 172]}], "size": 2, "samples": [{"hash": "lOHB2hUNj9H", "uri": "http://investors.abbvie.com/static-files/5c38fd3c-a283-4318-a783-63ed8774e460", "label": "investors.abbvie.com", "score": 9.9637234771, "published": false}, {"hash": "aOdCGp0vYyx", "uri": "https://investors.abbvie.com/static-files/5c38fd3c-a283-4318-a783-63ed8774e460", "label": "investors.abbvie.com", "score": 9.8432580424, "published": false}], "hash": "92a9f3c7cf6cd7af9b4152dfd4a59914", "id": 8}, {"snippet": "has the meaning given to that term in the Preamble. \u201cAbbVie Group\u201d means AbbVie and all of its Subsidiaries.", "snippet_links": [{"key": "the-preamble", "type": "clause", "offset": [38, 50]}, {"key": "abbvie-group", "type": "definition", "offset": [53, 65]}], "size": 2, "samples": [{"hash": "9BtfYGJmk1A", "uri": "/contracts/9BtfYGJmk1A#abbvie", "label": "Expense Reimbursement Agreement", "score": 30.3063257523, "published": true}, {"hash": "aPJ7hwRehCI", "uri": "/contracts/aPJ7hwRehCI#abbvie", "label": "Expense Reimbursement Agreement", "score": 25.7392197125, "published": true}], "hash": "7900d3a982e33c19a7bb4f414864edeb", "id": 9}, {"snippet": "has the meaning set forth in the preamble, and shall include its successors and permitted assigns.", "snippet_links": [{"key": "the-preamble", "type": "clause", "offset": [29, 41]}, {"key": "successors-and-permitted-assigns", "type": "clause", "offset": [65, 97]}], "size": 2, "samples": [{"hash": "1EHkMDXLbHI", "uri": "/contracts/1EHkMDXLbHI#abbvie", "label": "Master Program Services and Product Co Promotion Agreement (Orasure Technologies Inc)", "score": 25.9253935661, "published": true}, {"hash": "hj8VBlbYMAn", "uri": "/contracts/hj8VBlbYMAn#abbvie", "label": "Master Program Services and Product Co Promotion Agreement (Orasure Technologies Inc)", "score": 25.5941136208, "published": true}], "hash": "83a4c90bf0ebb3bdab10e137abdbe4e5", "id": 10}], "next_curs": "ClMSTWoVc35sYXdpbnNpZGVyY29udHJhY3Rzci8LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIPYWJidmllIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "has the meaning set forth in the preamble hereto.", "title": "AbbVie", "size": 104, "id": "abbvie", "examples": [], "related": [["abbott", "Abbott", "Abbott"], ["pfizer", "Pfizer", "Pfizer"], ["novartis", "Novartis", "Novartis"], ["bms", "BMS", "BMS"], ["merck", "Merck", "Merck"]], "related_snippets": [], "updated": "2025-07-07T00:16:55+00:00"}, "json": true, "cursor": ""}}